NCT02416570 Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer? Status TERMINATED Phase PHASE2
NCT02414672 CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients Status COMPLETED Phase NA
NCT02414269 Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02410603 Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer Status COMPLETED Phase N/A
NCT02407509 Phase I Trial of VS-6766 Alone and in Combination With Everolimus Status COMPLETED Phase PHASE1
NCT02407171 Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC Status COMPLETED Phase PHASE1/PHASE2
NCT02395939 Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL Status UNKNOWN Phase PHASE3
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Status TERMINATED Phase PHASE1/PHASE2
NCT02388074 Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer Status COMPLETED Phase NA
NCT02385812 Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma Status TERMINATED Phase PHASE2
NCT02379039 Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer Status COMPLETED Phase N/A
NCT02375022 Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations Status UNKNOWN Phase PHASE2
NCT02370303 A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System Status COMPLETED Phase N/A
NCT02361099 SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse Status COMPLETED Phase PHASE3
NCT02357992 Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy Status COMPLETED Phase NA